Kailera Therapeutics (KLRA)
Nasdaq • KLRA • US4829311020
ORTEX Data Highlights
ORTEX Data Highlights
As of Oct 27, 2026, ORTEX estimated 14.2% of free float sold short, 6.3 days to cover, cost to borrow 0.93%. Sign up for live short interest data.
Market Cap
1.85b USD | # 4047 in US
Volume
1.09m shares | 15.08m USD
Shares Outstanding
129.85m
Free Float Shares
45.19% | 58.68m
